![PDF) Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries PDF) Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries](https://i1.rgstatic.net/publication/281232424_Organisation_of_diagnosis_and_treatment_of_idiopathic_pulmonary_fibrosis_and_other_interstitial_lung_diseases_in_the_Nordic_countries/links/5601bd1308aed9851827cb52/largepreview.png)
PDF) Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
![Indremedisineren. LIS i akuttmottak s. 38. Endoskopisk behandling av øvre GI-blødning s. 7. Idiopatisk lungefibrose (IPF) s PDF Gratis nedlasting Indremedisineren. LIS i akuttmottak s. 38. Endoskopisk behandling av øvre GI-blødning s. 7. Idiopatisk lungefibrose (IPF) s PDF Gratis nedlasting](https://docplayer.me/docs-images/40/2867381/images/page_4.jpg)
Indremedisineren. LIS i akuttmottak s. 38. Endoskopisk behandling av øvre GI-blødning s. 7. Idiopatisk lungefibrose (IPF) s PDF Gratis nedlasting
![Tomas EAGAN | Professor | M.D, Ph.D. | University of Bergen, Bergen | UiB | Department of Clinical Science Tomas EAGAN | Professor | M.D, Ph.D. | University of Bergen, Bergen | UiB | Department of Clinical Science](https://i1.rgstatic.net/ii/profile.image/11431281083916975-1662889265298_Q512/Tomas-Eagan.jpg)
Tomas EAGAN | Professor | M.D, Ph.D. | University of Bergen, Bergen | UiB | Department of Clinical Science
![Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real‐world multicentre cohort - Durheim - 2021 - Respirology - Wiley Online Library Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real‐world multicentre cohort - Durheim - 2021 - Respirology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2343d1d3-4925-45df-87aa-06bf6147c40c/resp14116-fig-0005-m.jpg)
Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real‐world multicentre cohort - Durheim - 2021 - Respirology - Wiley Online Library
![ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF | BMJ Open Respiratory Research ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF | BMJ Open Respiratory Research](https://bmjopenrespres.bmj.com/content/bmjresp/7/1/e000598/F1.large.jpg)
ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF | BMJ Open Respiratory Research
![ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF | BMJ Open Respiratory Research ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF | BMJ Open Respiratory Research](https://bmjopenrespres.bmj.com/content/bmjresp/7/1/e000598/F2.large.jpg)